HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Imipenem

HCID 104838
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
64221-86-9
Standard SMILES
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCCN=CN)C[C@H]12
InChIKey
ZSKVGTPCRGIANV-ZXFLCMHBSA-N
Molecular formula
C12H17N3O4S
Average molar mass
299.35 g/mol
Monoisotopic mass
299.09397721

Overview

Imipenem is a broad-spectrum, intravenous beta-lactam antibiotic of the carbapenem subgroup. It has a role as an antibacterial drug. It is a member of carbapenems and a beta-lactam antibiotic allergen. It is a tautomer of an imipenem zwitterion.

Names & identifiers

Preferred name
Imipenem
IUPAC
(5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
English name
Imipenem
Molecular formula
C12H17N3O4S
Molecular weight
299.35

Names & synonyms

imipenem64221-86-9ImipemideImipenem anhydrousN-FormimidoylthienamycinImipenemumN-formimidoyl thienamycinAnhydrous Imipenem(5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acidMK 0787DTXSID2023143CHEBI:471744
Show more names
imipenamImipenenLMipeneMImipenem CRS(5R)-6β-[(R)-1-Hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid(5R,6S)-3-({2-[(E)-(aMinoMethylidene)aMino]ethyl}sulfanyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acidmk-787EOS-62374
Imipenem, AnhydrousMK-0787Q20IM7HE75(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acidDTXCID903143Imipenem monohydrate (h2o)RECARBRIO COMPONENT IMIPENEM

Properties

Computed structural properties

XLogP
-0.7
Topological polar surface area
142 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
6
Rotatable bonds
6
Heavy atoms
20
Formal charge
0
Complexity
491

Experimental & physicochemical properties

Drugs · 3 items

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Antibiotics

Solubility7.76e-01 g/L
Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physical DescriptionSolid
Dissociation Constants3.2
Collision Cross Section169.26 Ų [M+H]+

Physicochemical properties

Melting point
106 · 106-111 C
Boiling point
530.2 · 530.2±60.0 °C(Predicted)
Density
1.62 · 1.62±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Keep in dark place,Sealed in dry,Store in freezer, under -20°C

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Exposure RoutesImipenem is not effectively absorbed from the gastrointestinal tract and therefore must be administered parenterally.
Toxicity Summary · 1 item

Imipenem acts as an antimicrobial through the inhibition of cell wall synthesis of various gram-positive and gram-negative bacteria. This inhibition of cell wall synthesis in gram-negative bateria is attained by binding to pencillin binding proteins (PBPs). In E. coli and selected strains of P. aeruginosa, imipenem has shown to have the highest affinity to PBP-2, PBP-1a, and PBP-1b. This preferential binding to PBP-2 and PBP-1b results in the direct conversion of the individual cell to a spheroblast, which leads to rapid cell lysis and death without filament formation.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 5 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Imipenem

DILI Positive

Intravenous

DOI:10.1016/j.drudis.2019.09.022

Safety data

wgk
WGK 3
hs_code
29419000
risk_code
36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xi
safety_code
26-27-36/37/39
Storage Class
11 - Combustible Solids
Hazard statements
H315-H319-H335
Precautionary statements

Chemistry & industry

Pharmacology

ATC CodeJ01DH51
Protein BindingImipenem is 20% bound to plasma proteins.
Pharmacodynamics · 1 item

Imipenem is a beta-lactam antibiotic belongings to the subgroup of carbapenems. Imipenem is active against aerobic and anaerobic Gram positive as well as Gram negative bacteria including <i>Pseudomonas aeruginosa</i> and the <i>Enterococcus</i>. It exerts a bactericidal effects by disrupting cell wall synthesis.

Mechanism of Action · 1 item

Imipenem acts as an antimicrobial through the inhibition of cell wall synthesis of various gram-positive and gram-negative bacteria. This inhibition of cell wall synthesis in gram-negative bateria is attained by binding to penicillin-binding proteins (PBPs). In E. coli and selected strains of P. aeruginosa, imipenem has shown to have the highest affinity to PBP-2, PBP-1a, and PBP-1b. This inhibition of PBPs prevents the bacterial cell from adding to the peptidoglycan polymer which forms the bacterial cell wall eventually leading to cell death.

Biological Half-LifeWhen given via IV injection imipenem has a half-life of 1 h. The apparent half-life of the IM injection ranges from 1.3-5.1 h, likely due to slower absorption form the injection site.
Metabolism/Metabolites · 2 items

Imipenem is metabolized by renal dehydropeptidase.

Renal. Half Life: 1 hour

FDA Pharmacological Classification · 5 items

Q20IM7HE75

IMIPENEM ANHYDROUS

Chemical Structure [CS] - Carbapenems

Established Pharmacologic Class [EPC] - Penem Antibacterial

Imipenem anhydrous is a Penem Antibacterial.

MeSH Pharmacological ClassificationSubstances that inhibit the growth or reproduction of BACTERIA.

Related reactions

2 records
New reaction record
HRID 224412 reaction equation
HRID 224412As product
HRID 1156231 reaction equation
HRID 1156231As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
64221-86-9、74431-23-5
PubChem CID
104838
DTXSID
DTXSID2023143
ChEMBL
CHEMBL148、CHEMBL43708
ChEBI
CHEBI:471744
UNII
Q20IM7HE75
EC Number
264-734-5
Nikkaji
J32.525B
solubility
Sparingly soluble in water, slightly soluble in methanol.
form
Solid
pka
4.29 · 4.29±0.40(Predicted)
color
Off-white to yellow
Major Application
pharmaceutical (small molecule)
InChI
InChI=1S/C12H17N3O4S/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19)/t6-,7-,9-/m1/s1
InChIKey
ZSKVGTPCRGIANV-ZXFLCMHBSA-N
SMILES
N12[C@@]([H])([C@@H]([C@H](O)C)C1=O)CC(SCCNC=N)=C2C(O)=O
CAS DataBase Reference
64221 · 64221-86-9(CAS DataBase Reference)
FDA UNII
20 IM7HE75 · Q20IM7HE75
EPA Substance Registry System
Imipenem (64221-86-9)
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319-H335
Precautionary statements
280 · P280-P261
Hazard Codes
Xi
Risk Statements
36 · 36/37/38
Safety Statements
26 · 26-27-36/37/39
WGK Germany
3 · WGK 3
HS Code
29419000 · 29419000
Storage Class
11 · 11 - Combustible Solids
P280-P261
Absorption, Distribution and Excretion · 4 items

Imipenem is not effectively absorbed from the gastrointestinal tract and therefore must be administered parenterally. The bioavailability of the IM injection is 89%.

Approximately 70% of imipenem is excreted in the urine as the parent drug.

The reported volume of distribution for imipenem ranges from 0.23-0.31 L/kg.

The total clearance of imipenem is 0.2 L/h/kg. When used alone, the renal clearance is 0.05 L/h/kg. In combination with cilastatin the renal clearance of imipenem is 0.15 L/h/kg, likely due to the increased concentration of the parent drug.

Cellular LocationsCytoplasm

Uses & manufacturing

Uses · 2 items

Use (kg) in Switzerland (2009): >100

For the treatment of bacterial infections caused by susceptible bacteria.

Applications · 3 items

DescriptionImipenem is a chemically stable thienamycin derivative with an antibacterial activity that is broader in spectrum and of greater potency than most of the third generation cephalosporins. Combination with cilastatin, an inhibitor of renal brush-border dehydropeptidase-I, increases both urinary and plasma levels of imipenem.

UsesCarbapenem antibacterial.

General DescriptionThienamycin was found in the culture broth of Streptomyces cattleya by Merck Sharp & Dohme in 1976, as a very unstable substance. It has a unique carbapenem structure, like that of the olivanic acids found in S. olivaceus by Beecham Research Laboratories in 1979. Thienamycin shows excellent activity against a variety of pathogenic bacteria, including Pseudomonas aeruginosa. Its chemical stability has been improved by derivatization with the formimidoyl group, and its biological stability has been improved by combining it with cilastatin, an inhibitor of kidney dihydropeptidase. The combination drug imipenem – cilastatin is now under study to evaluate its clinical efficacy and safety.

Upstream & downstream products

Upstream raw materials

Thienamycin
Additional notes · 1 item

DefinitionChEBI: Imipenem is a broad-spectrum, intravenous beta-lactam antibiotic of the carbapenem subgroup. It has a role as an antibacterial drug. It is a beta-lactam antibiotic allergen and a member of carbapenems. It is a tautomer of an imipenem zwitterion.